2627 — Ab&B Bio Tech Co JS Cashflow Statement
0.000.00%
Last trade - 00:00- HK$17.00bn
- HK$17.88bn
- CNY259.61m
Annual cashflow statement for Ab&B Bio Tech Co JS, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -425 | -259 |
| Depreciation | ||
| Amortisation | ||
| Non-Cash Items | 95.3 | 76.1 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | -24.5 | -76.1 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Other Assets | ||
| Change in Payable / Accrued Expenses | ||
| Change in Other Liabilities | ||
| Cash from Operating Activities | -306 | -200 |
| Capital Expenditures | -291 | -200 |
| Purchase of Fixed Assets | ||
| Purchase / Acquisition of Intangibles | ||
| Other Investing Cash Flow Items | 291 | 47.5 |
| Sale of Fixed Assets | ||
| Sale/Maturity of Investment | ||
| Purchase of Investments | ||
| Other Investing Cash Flow | ||
| Cash from Investing Activities | -0.506 | -153 |
| Financing Cash Flow Items | -6.83 | -11.8 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 335 | 439 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 28.7 | 86.9 |